Core Viewpoint - Pfizer's stock experienced a 5.04% increase on August 5, reaching $24.715 per share, with a total market capitalization of $140.517 billion [1]. Financial Performance - As of March 30, 2025, Pfizer reported total revenue of $13.715 billion, a year-over-year decrease of 7.82% [1]. - The company's net profit attributable to shareholders was $2.967 billion, reflecting a year-over-year decline of 4.75% [1]. Company Overview - Pfizer is committed to improving health at every stage of life through scientific innovation and global resources [2]. - The company offers a diverse range of healthcare products, including biologics, small molecule drugs, and vaccines, and collaborates with healthcare professionals, governments, and communities worldwide [2]. - With over 160 years of history, Pfizer aims to provide better and higher-quality healthcare services [2].